{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:52:27Z","timestamp":1784130747187,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10515-1","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T01:39:08Z","timestamp":1747359548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prediction of early relapse in multiple myeloma patients after Autologous hematopoietic stem cell transplantation by miR-21 and miR-181a"],"prefix":"10.1007","volume":"52","author":[{"given":"Meysam","family":"Kashiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Zehtabcheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setare","family":"Kheyrandish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Hamidpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rafiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8697-1371","authenticated-orcid":false,"given":"Mohammad Hossein","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"issue":"11","key":"10515_CR1","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.3390\/cancers11111738","volume":"11","author":"H Handa","year":"2019","unstructured":"Handa H, Murakami Y, Ishihara R, Kimura-Masuda K, Masuda Y (2019) The role and function of MicroRNA in the pathogenesis of multiple myeloma. Cancers 11(11):1738","journal-title":"Cancers"},{"key":"10515_CR2","doi-asserted-by":"publisher","first-page":"154715","DOI":"10.1016\/j.prp.2023.154715","volume":"248","author":"AM Yehia","year":"2023","unstructured":"Yehia AM, Elsakka EGE, Abulsoud AI, Abdelmaksoud NM, Elshafei A, Elkhawaga SY et al (2023) Decoding the role of MiRNAs in multiple myeloma pathogenesis: A focus on signaling pathways. Pathol Res Pract 248:154715","journal-title":"Pathol Res Pract"},{"issue":"11","key":"10515_CR3","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1182\/blood.V106.11.1554.1554","volume":"106","author":"A Al Masri","year":"2005","unstructured":"Al Masri A, Price-Troska T, Chesi M, Chung T-H, Kim S, Carpten J et al (2005) MicroRNA expression analysis in multiple myeloma. Blood 106(11):1554","journal-title":"Blood"},{"issue":"35","key":"10515_CR4","doi-asserted-by":"publisher","first-page":"12885","DOI":"10.1073\/pnas.0806202105","volume":"105","author":"F Pichiorri","year":"2008","unstructured":"Pichiorri F, Suh S-S, Ladetto M, Kuehl M, Palumbo T, Drandi D et al (2008) MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci 105(35):12885\u201312890","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"10515_CR5","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1158\/1078-0432.CCR-12-3325","volume":"19","author":"E Leone","year":"2013","unstructured":"Leone E, Morelli E, Di Martino MT, Amodio N, Foresta U, Gull\u00e0 A et al (2013) Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth. Clin Cancer Res 19(8):2096\u20132106","journal-title":"Clin Cancer Res"},{"issue":"37","key":"10515_CR6","doi-asserted-by":"publisher","first-page":"60723","DOI":"10.18632\/oncotarget.11032","volume":"7","author":"J Abdi","year":"2016","unstructured":"Abdi J, Jian H, Chang H (2016) Role of micro-RNAs in drug resistance of multiple myeloma. Oncotarget 7(37):60723","journal-title":"Oncotarget"},{"issue":"8","key":"10515_CR7","doi-asserted-by":"publisher","first-page":"e103373","DOI":"10.1371\/journal.pone.0103373","volume":"9","author":"W Zhu","year":"2014","unstructured":"Zhu W, Xu B (2014) MicroRNA-21 identified as predictor of cancer outcome: a meta-analysis. PLoS ONE 9(8):e103373","journal-title":"PLoS ONE"},{"issue":"1","key":"10515_CR8","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3892\/ol.2020.11579","volume":"20","author":"X Yan","year":"2020","unstructured":"Yan X, Gao M, Zhang P, Ouyang G, Mu Q, Xu K (2020) MiR\u2013181a functions as an oncogene by regulating CCND1 in multiple myeloma. Oncol Lett 20(1):758\u2013764","journal-title":"Oncol Lett"},{"issue":"3","key":"10515_CR9","doi-asserted-by":"publisher","first-page":"e59532","DOI":"10.1371\/journal.pone.0059532","volume":"8","author":"S Lin","year":"2013","unstructured":"Lin S, Pan L, Guo S, Wu J, Jin L, Wang J-C et al (2013) Prognostic role of microRNA-181a\/b in hematological malignancies: a meta-analysis. PLoS ONE 8(3):e59532","journal-title":"PLoS ONE"},{"issue":"21","key":"10515_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1182\/blood.V122.21.122.122","volume":"122","author":"M Fulciniti","year":"2013","unstructured":"Fulciniti M, Amodio N, Bandi R, Prabhala RH, Adamia S, Calimeri T et al (2013) Mir-23b plays a critical role as a tumor suppressor MiRNA in multiple myeloma. Blood 122(21):122","journal-title":"Blood"},{"issue":"2","key":"10515_CR11","doi-asserted-by":"publisher","first-page":"103920","DOI":"10.1016\/j.sjbs.2023.103920","volume":"31","author":"MS Abduh","year":"2024","unstructured":"Abduh MS (2024) An overview of multiple myeloma: A monoclonal plasma cell malignancy\u2019s diagnosis, management, and treatment modalities. Saudi J Biol Sci 31(2):103920","journal-title":"Saudi J Biol Sci"},{"issue":"1","key":"10515_CR12","first-page":"1","volume":"16","author":"M Sohani","year":"2024","unstructured":"Sohani M, Rastgar A, Kheyrandish S (2024) Harnessing the power of MAGE proteins in cancer immunotherapy for multiple myeloma. Iran J Blood Cancer 16(1):1\u201320","journal-title":"Iran J Blood Cancer"},{"issue":"5","key":"10515_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA et al (2022) Diagnosis and management of multiple myeloma: a review. JAMA 327(5):464\u2013477","journal-title":"JAMA"},{"issue":"1","key":"10515_CR14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s11033-024-09650-y","volume":"51","author":"A Rastgar","year":"2024","unstructured":"Rastgar A, Kheyrandish S, Vahidi M, Heidari R, Ghorbani M (2024) Advancements in small interfering RNAs therapy for acute lymphoblastic leukemia: promising results and future perspectives. Mol Biol Rep 51(1):737","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10515_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/ijo.2016.3503","volume":"49","author":"R Gambari","year":"2016","unstructured":"Gambari R, Brognara E, Spandidos DA, Fabbri E (2016) Targeting OncomiRNAs and mimicking tumor suppressor MiRNAs: \u039dew trends in the development of MiRNA therapeutic strategies in oncology. Int J Oncol 49(1):5\u201332","journal-title":"Int J Oncol"},{"issue":"21","key":"10515_CR16","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood.V124.21.2043.2043","volume":"124","author":"L Kubiczkova-Besse","year":"2014","unstructured":"Kubiczkova-Besse L, Sedlarikova L, Kryukov F, Radova L, Nekvindova J, Nemec P et al (2014) Circulating miR-130a in multiple myeloma and extramedullary myeloma patients. Blood 124(21):2043","journal-title":"Blood"},{"key":"10515_CR17","doi-asserted-by":"publisher","first-page":"175233","DOI":"10.1016\/j.ejphar.2022.175233","volume":"932","author":"T Akhtarkhavari","year":"2022","unstructured":"Akhtarkhavari T, Bahrami AR, Matin MM (2022) Downregulation of miR-21 as a promising strategy to overcome drug resistance in cancer. Eur J Pharmacol 932:175233","journal-title":"Eur J Pharmacol"},{"key":"10515_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jocn.2017.07.040","volume":"46","author":"C Lv","year":"2017","unstructured":"Lv C, Yang S, Chen X, Zhu X, Lin W, Wang L et al (2017) MicroRNA-21 promotes bone mesenchymal stem cells migration in vitro by activating PI3K\/Akt\/MMPs pathway. J Clin Neurosci 46:156\u2013162","journal-title":"J Clin Neurosci"},{"key":"10515_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s13258-017-0518-7","volume":"39","author":"IPN Bong","year":"2017","unstructured":"Bong IPN, Ng CC, Baharuddin P, Zakaria Z (2017) MicroRNA expression patterns and target prediction in multiple myeloma development and malignancy. Genes Genomics 39:533\u2013540","journal-title":"Genes Genomics"},{"issue":"3","key":"10515_CR20","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.18632\/oncotarget.2761","volume":"6","author":"A Navarro","year":"2015","unstructured":"Navarro A, D\u00edaz T, Tovar N, Pedrosa F, Tejero R, Cibeira MT et al (2015) A serum MicroRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma. Oncotarget 6(3):1874","journal-title":"Oncotarget"},{"issue":"33","key":"10515_CR21","doi-asserted-by":"publisher","first-page":"e16711","DOI":"10.1097\/MD.0000000000016711","volume":"98","author":"P Xu","year":"2019","unstructured":"Xu P, Xia T, Ling Y, Chen B (2019) MiRNAs with prognostic significance in multiple myeloma: A systemic review and meta-analysis. Medicine 98(33):e16711","journal-title":"Medicine"},{"issue":"19","key":"10515_CR22","doi-asserted-by":"publisher","first-page":"11389","DOI":"10.3390\/ijms231911389","volume":"23","author":"C Zhang","year":"2022","unstructured":"Zhang C, Sun C, Zhao Y, Wang Q, Guo J, Ye B et al (2022) Overview of MicroRNAs as diagnostic and prognostic biomarkers for high-incidence cancers in 2021. Int J Mol Sci 23(19):11389","journal-title":"Int J Mol Sci"},{"key":"10515_CR23","doi-asserted-by":"publisher","first-page":"106568","DOI":"10.1016\/j.phrs.2022.106568","volume":"187","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Mirdamadi MSA, Talebi Y, Khaniabad N, Banaei G, Daneii P et al (2023) Pre-clinical and clinical importance of miR-21 in human cancers: tumorigenesis, therapy response, delivery approaches and targeting agents. Pharmacol Res 187:106568","journal-title":"Pharmacol Res"},{"key":"10515_CR24","doi-asserted-by":"crossref","unstructured":"Wang J, Zhou W, Liu B, Man D, Yang Z, Liu F et al (2016) Expression and significance of miR-21 in multiple myeloma patients. Genet Mol Res. 15(1)","DOI":"10.4238\/gmr.15016892"},{"issue":"1","key":"10515_CR25","first-page":"291","volume":"42","author":"N Liu","year":"2019","unstructured":"Liu N, Yang J, Yuan R, Peng J, Liu L, Guo X (2019) Effects of miR-181a on the biological function of multiple myeloma. Oncol Rep 42(1):291\u2013300","journal-title":"Oncol Rep"},{"issue":"23","key":"10515_CR26","first-page":"2856","volume":"127","author":"GA Kozloski","year":"2016","unstructured":"Kozloski GA, Jiang X, Bhatt S, Ruiz J, Vega F, Shaknovich R et al (2016) miR-181a negatively regulates NF-\u03baB signaling and affects activated B-cell\u2013like diffuse large B-cell lymphoma pathogenesis. Blood. J Am Soc Hematol 127(23):2856\u20132866","journal-title":"J Am Soc Hematol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10515-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10515-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10515-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:28:01Z","timestamp":1766852881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10515-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10515"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10515-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"460"}}